Skip to main content
Joshua Field, MD, Oncology, Milwaukee, WI, Froedtert and the Medical College of Wisconsin Froedtert Hospital

JoshuaJFieldMD

Oncology Milwaukee, WI

Assistant Professor, Medicine, Medical College of Wisconsin

Dr. Field is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Field's full profile

Already have an account?

  • Office

    9200 W Wisconsin Ave
    Division Of Neoplastic Diseases
    Milwaukee, WI 53226
    Phone+1 414-805-6800
    Fax+1 414-805-6805
  • Is this information wrong?

Education & Training

  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 2004 - 2007
  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumFellowship, Blood Banking/Transfusion Medicine, 2005 - 2006
  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2001 - 2004
  • University of Iowa Roy J. and Lucille A. Carver College of Medicine
    University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 2001

Certifications & Licensure

  • WI State Medical License
    WI State Medical License 2010 - 2025
  • American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Fostamatinib, a Spleen Tyrosine Kinase (SYK) Inhibitor, for the Treatment of Warm Antibody Autoimmune Hemolytic Anemia (wAIHA): Final Results of the Phase 2, Multicent...
    Joshua J. Field, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Chronic Kidney Disease Is Under-Screened in SCD and Mild Albuminuria Is Associated with a Drop in Hemoglobin: A Report from the Grndad Sickle Cell Registry
    Joshua J. Field, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

  • Iron Overload Is Under-Recognized and Under-Treated in SCD: A Report from the GRNDaD Registry 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Other

Press Mentions

  • New Sickle Cell Anemia Therapy Advances to Phase II Clinical Trials
    New Sickle Cell Anemia Therapy Advances to Phase II Clinical TrialsJune 12th, 2013

Hospital Affiliations